Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

New Cures for Large B Cell Diffuse Lymphoma

Summary by Askanews
Milan, 16 sets. (askanews) • A new therapeutic option for patients with relapsed or refractory large B cell lymphoma. It is also available and refunded in Italy the combination of glofitamab and GemOx chemotherapy, from the second line of treatment. A novelty that comes after the results of the international phase III study STARGLO. [...]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

Il TempoIl Tempo
+3 Reposted by 3 other sources

New Cures for Large B Cell Diffuse Lymphoma

Milan, 16 Sep. (askanews) - A new therapeutic option for patients with relapsed or refractory large B cell lymphoma. The combination of glofitamab and GemOx chemotherapy is also available and refunded in Italy, from the second line of treatment. A novelty that comes after the results of the international phase III STARGLO study. The study showed a significant improvement in overall survival and progression-free survival compared to the standard …

·Rome, Italy
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

notizie.it broke the news on Wednesday, September 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Milan, Lombardy icon

Milan, Lombardy

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal